Fluid-Screen
About Fluid-Screen
Fluid-Screen, Inc. (FSI) is a Yale-spin off and an award-winning early-stage company based in Boston, MA. FSI has developed a microchip to enable two day turnaround on the newest cancer treatments. We drastically reduce testing times from days to minutes. The company specializes in applying cutting edge microelectronic technology to develop rapid microbiology testing solutions for a range of industries including CAR-T manufacturing, cell and gene therapy, pharmaceutical manufacturing, and medical diagnostics. We are developing our first product, a bacterial detection chip, for use in sterile manufacturing processes. Our mission and a long-term goal is to enable safer living for millions of people worldwide. Fluid Screen’s lab-on-a-chip system and the team have been recognized with the Grand Prize in the Create the Future NASA Design contest (#1 out of 900 entrants worldwide), a Gold Prize in the Mass Challenge (top 1% of contenders), and ten other awards.